EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Mesenchymal Stem Cell-Derived Exosomes for Bone Regeneration: Modification Strategies and miRNA-Mediated Modulation of Osteogenic Signaling

Anastasiia Meglei iD, Daria Paymeteva, Irina Nedorubova iD, Viktoriia Basina iD, Dmitry Goldshtein, Tatiana Bukharova iD

International Journal of Molecular Sciences · 23.10.2026 · 27 (21) · 9486

DOI: 10.3390/ijms27219486 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 23.10.2026. Verfasst von Anastasiia Meglei und 5 weiteren Autor:innen. Beteiligte Einrichtung: Research Centre for Medical Genetics, 115478 Moscow, Russia. Hauptthemen laut MEDLINE: Exosomes, Mesenchymal Stem Cells, Bone Regeneration, MicroRNAs. Die Arbeit nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education of the Russian Federation for the Research Centre for Medical Genetics.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bone tissue regeneration remains a major clinical challenge, and exosomes secreted by mesenchymal stem cells (MSCs) have emerged as attractive cell-free therapeutic tools. To enhance their efficacy and local action, exosomes can be modified to enrich them with regulatory factors and impregnated into biocompatible matrices. This review summarizes recent advances in engineering MSC-derived exosomes for bone regeneration. Strategies analyzed include physicochemical modification of donor MSCs, direct exosome modification, and genetic modification of MSCs to enrich exosomes with therapeutic molecules such as bone morphogenetic protein 2 (BMP-2), vascular endothelial growth factor (VEGF), and regulatory miRNAs. In addition, the role of these miRNAs in osteogenic signaling was analyzed. Modified exosomes demonstrate enhanced osteogenic, angiogenic, and immunomodulatory effects in vitro and in vivo, particularly when combined with biomaterial scaffolds for sustained release. Thus, engineered MSC-derived exosomes constitute an effective approach for bone tissue engineering and show potential for clinical translation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ExosomesMesenchymal Stem CellsBone RegenerationMicroRNAsOsteogenesisHumansAnimalsSignal TransductionTissue Engineering

Stichwörter der Autor:innen

BMP2bone tissue regenerationexosomesgene-modified exosomesimmunomodulationmesenchymal stem cellsosteogenesis

Substanzen

MicroRNAs

Autor:innen und Institutionen

  • Research Centre for Medical Genetics, 115478 Moscow, Russia.

ORCID-Profile: Anastasiia Meglei, Irina Nedorubova, Viktoriia Basina, Tatiana Bukharova

Förderung

  • Ministry of Science and Higher Education of the Russian Federation for the Research Centre for Medical Genetics

Zitieren

APA

Meglei, A., Paymeteva, D., Nedorubova, I., Basina, V., Goldshtein, D., & Bukharova, T. (2026). Mesenchymal Stem Cell-Derived Exosomes for Bone Regeneration: Modification Strategies and miRNA-Mediated Modulation of Osteogenic Signaling. International Journal of Molecular Sciences, 27(21), 9486. https://doi.org/10.3390/ijms27219486

Vancouver

Meglei A, Paymeteva D, Nedorubova I, Basina V, Goldshtein D, Bukharova T. Mesenchymal Stem Cell-Derived Exosomes for Bone Regeneration: Modification Strategies and miRNA-Mediated Modulation of Osteogenic Signaling. International Journal of Molecular Sciences. 2026;27(21):9486. doi:10.3390/ijms27219486

BibTeX
@article{Meglei2026,
  author = {Meglei, Anastasiia and Paymeteva, Daria and Nedorubova, Irina and Basina, Viktoriia and Goldshtein, Dmitry and Bukharova, Tatiana},
  title = {Mesenchymal Stem Cell-Derived Exosomes for Bone Regeneration: Modification Strategies and miRNA-Mediated Modulation of Osteogenic Signaling},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {21},
  pages = {9486},
  doi = {10.3390/ijms27219486}
}
Kostenlos starten →